Ashley Crane, MD
Ophthalmology · Tampa, FLNPI 1225460371
Payments from drug & device makers
Across 407 payments — averaging $1205.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$253K
- Ocular Therapeutix, Inc.$199K
- Eyepoint US, Inc.$11K
- AbbVie$10K
- Genentech USA, Inc.$7K
- Regeneron Healthcare Solutions, Inc.$2K
- plus $10K from 25 others
Across 1 payment — averaging $14,618 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ocular Therapeutix, Inc.$15K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 100 | $252,579 |
| Ocular Therapeutix, Inc. | 26 | $198,630 |
| Eyepoint US, Inc. | 7 | $11,103 |
| AbbVie(2 entities) | 28 | $9,848 |
| Genentech USA, Inc. | 57 | $6,730 |
| Regeneron Healthcare Solutions, Inc. | 54 | $2,018 |
| Alimera Sciences, Inc. | 13 | $1,634 |
| Alcon | 15 | $1,412 |
| Harrow Eye, LLC | 15 | $1,132 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $644 |
| Astellas Pharma US Inc | 14 | $598 |
| Amgen | 5 | $561 |
| Apellis Pharmaceuticals, Inc. | 10 | $549 |
| Sun Pharmaceutical Industries Inc. | 6 | $488 |
| Novartis | 11 | $470 |
| Dutch Ophthalmic, USA | 5 | $416 |
| Glaukos Corporation | 4 | $376 |
| Sandoz | 6 | $192 |
| NEW World Medical,inc. | 1 | $142 |
| Tarsus Pharmaceuticals, Inc. | 1 | $137 |
| Hoffmann-la Roche Limited | 1 | $133 |
| Kala Pharmaceuticals, Inc. | 1 | $125 |
| Dompe US, Inc. | 1 | $122 |
| Sight Sciences, Inc. | 1 | $120 |
| ANI Pharmaceuticals, Inc. | 3 | $94 |
| Notal Vision, Inc. | 1 | $86 |
| Coherus Oncology, Inc. | 4 | $79 |
| Bausch & Lomb Americas Inc. | 3 | $65 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Biogen | 1 | $15 |
| US Retina LLC | 1 | $0 |
How this compares
$490,537 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Tampa
- Ivan SunerTampa$3.7M
- Pedram HamrahTampa$2.2M
- Thomas NewsomTampa$1.5M
- Courtney BoveeTampa$884K
- Don PerezTampa$367K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.